ANIMATION

Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

XVIVO was an absolute pleasure to work with. Our project with XVIVO was our very first animation project and their team guided us through the process with no difficulty. The people that we worked with were very talented and made the whole process enjoyable. Their attention to the details was superb. We are completely satisfied with the end result and is a product that we can continue to use in the future. We will work with them again.

Manager, New Business Development, Ajinomoto
Share this animation: